This inventor holds 1 USPTO granted patent. Top assignee: Transparent Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations of Wenjie Wang in Stem Cell Research
Introduction
Wenjie Wang is a prominent inventor based in Tokyo, Japan, known for her groundbreaking work in the field of stem cell research. She has made significant contributions to reconstructive medicine through her innovative approaches to cultured cell construction.
Latest Patents
Wenjie Wang holds a patent for a "Cultured cell construction containing spheroids of mesenchymal stem cells and utilization thereof." This invention addresses the ethical challenges often associated with stem cell research. It introduces a 3D multicellular spheroid culture construction based on photolithography and micropatterning techniques. This method enhances the multipotent differentiation efficiency of mesenchymal stem cells (MSCs) into adult cells. The invention comprises a support with at least one island, a hydrophilic and cytophobic substance applied to encircle the island, and a spheroid derived from MSCs in contact with the island. This innovative construction significantly improves the differentiation efficiency of MSCs.
Career Highlights
Wenjie Wang is associated with Transparent Inc., where she continues to advance her research and development in stem cell technologies. Her work has positioned her as a key figure in the field, contributing to the understanding and application of MSCs in medical treatments.
Collaborations
Wenjie has collaborated with notable colleagues, including Keiji Itaka and Shinsuke Ohba, to further enhance the impact of her research in the scientific community.
Conclusion
Wenjie Wang's contributions to stem cell research through her innovative patent demonstrate her commitment to advancing medical science. Her work not only addresses ethical concerns but also paves the way for future developments in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile